Publication Name	World Journal of Clinical Oncology
Manuscript ID	10447
Country	United States

Received	2014-04-01 10:06
Peer-Review Started	2014-04-02 21:34
To Make the First Decision	2014-04-28 14:31
Return for Revision	2014-04-30 18:03
Revised	2014-05-14 04:39
Second Decision	2014-06-11 14:11
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2014-06-11 14:31
Articles in Press	2014-06-11 15:03
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2014-07-21 16:07
Publish the Manuscript Online	2014-08-01 15:17

ISSN	2218-4333 (online)
Open Access
Copyright
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Oncology
Manuscript Type	Review
Article Title	Adjuvant chemotherapy in breast cancer: To use or not to use, the anthracyclines
Manuscript Source	Invited Manuscript
All Author List	Jennifer A Crozier, Abhisek Swaika and Alvaro Moreno-Aspitia
Funding Agency and Grant Number
Corresponding Author	Alvaro Moreno-Aspitia, MD, Associate Professor of Medicine, Department of Hematology and Oncology, Mayo Clinic, 4500 San Pablo Road, Jacksonville, FL 32224, United States. morenoaspitia.alvaro@mayo.edu
Key Words	Breast cancer; Adjuvant; Neoadjuvant; Chemotherapy; Anthracyclines
Core Tip	A better understanding of the tumor biology along with other effective novel therapeutic options, have revolutionized the treatment for breast cancer. The role of anthracyclines has come under close scrutiny, especially in the adjuvant setting for patients with early stage breast cancer and those with low or intermediate risk of disease recurrence, as per the recent studies. However, in patients with a high risk of relapse, anthracyclines still hold promise. Ongoing clinical trials are underway to further define the role of anthracyclines in such a patient population.
Publish Date	2014-08-01 15:17
Citation	Crozier JA, Swaika A, Moreno-Aspitia A. Adjuvant chemotherapy in breast cancer: To use or not to use, the anthracyclines. World J Clin Oncol 2014; 5(3): 529-538
URL	http://www.wjgnet.com/2218-4333/full/v5/i3/529.htm
DOI	http://dx.doi.org/10.5306/wjco.v5.i3.529

Full Article (PDF)	WJCO-5-529.pdf
Full Article (Word)	WJCO-5-529.doc
Manuscript File	10447-Review.docx
Answering Reviewers	10447-Answering reviewers.pdf
Copyright License Agreement	10447-Copyright assignment.pdf
Peer-review Report	10447-Peer review(s).pdf
Scientific Misconduct Check	10447-CrossCheck.jpg
Scientific Editor Work List	10447-Scientific editor work list.pdf